Advertisement

Index by author

February 01, 2012; Volume 340,Issue 2

  1. Vesey, David A.

    1. Antagonism of Protease-Activated Receptor 2 Protects against Experimental Colitis
      Rink-Jan Lohman, Adam J. Cotterell, Jacky Suen, Ligong Liu, Anh T. Do, David A. Vesey and David P. Fairlie
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 256-265; DOI: https://doi.org/10.1124/jpet.111.187062

  2. Vieira-brock, Paula L.

    1. Methamphetamine Self-Administration Causes Persistent Striatal Dopaminergic Alterations and Mitigates the Deficits Caused by a Subsequent Methamphetamine Exposure
      Lisa M. McFadden, Greg C. Hadlock, Scott C. Allen, Paula L. Vieira-Brock, Kristen A. Stout, Jonathan D. Ellis, Amanda J. Hoonakker, David M. Andrenyak, Shannon M. Nielsen, Diana G. Wilkins, Glen R. Hanson and Annette E. Fleckenstein
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 295-303; DOI: https://doi.org/10.1124/jpet.111.188433

  3. Vinall, Shân L.

    1. Pharmacologic Profile of OC000459, a Potent, Selective, and Orally Active D Prostanoid Receptor 2 Antagonist That Inhibits Mast Cell-Dependent Activation of T Helper 2 Lymphocytes and Eosinophils
      Roy Pettipher, Shân L. Vinall, Luzheng Xue, Graham Speight, Elizabeth R. Townsend, Lucien Gazi, Cliff J. Whelan, Richard E. Armer, Mark A. Payton and Michael G. Hunter
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 473-482; DOI: https://doi.org/10.1124/jpet.111.187203
Back to top

In this issue

Advertisement